Regulating Hemp and Cannabis-Based Products.

(1)Different state agencies often regulate the hemp and cannabis industries separately. (2) Pharmaceutical products derived from cannabis are currently in clinical trials for approval in the U.S. and other countries. One product is already approved for use in 29 countries, but not in the U.S. (3) In August 2017, NCSL unanimously approved a policy position supporting federal legislation to define industrial hemp as a distinct agricultural crop (containing 1 percent or less of THC) and allow states to regulate commercial hemp farming.